Immunodeficiency
Primary immunodeficiencies (PIDs) are a group of more than 400 potentially serious disorders that can lead to frequent or severe infections, swellings and autoimmune problems. PIDs can be caused by defects in genes that control the immune system, and may be inherited.
Information for Patients, Consumers and Carers
Immunoglobulin replacement therapy (IRT)
SCIg therapy - general information for patients and carers
Fast Facts about primary immunodeficiency
COVID-19 and Immunodeficiency Updated May 2020
COVID-19, Immunodeficiency and School Attendance Updated August 2020
Primary immunodeficiency (PIDs)
Severe combined immunodeficiency (SCID)
Common variable immunodeficiency (CVID)
Hereditary angiodema (HAE) - under development
Subcutaneous Immunogobulin (SCIg) Information
SCIg therapy - general information for patients and carers
SCIg information handouts for patients and carers (ASCIA member access only)
Guide - Setting up a SCIg service in a hospital
Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)
Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy
Other Information for Health Professionals
ASCIA Position Statement - Specific Treatments for COVID-19 New April 2020 (currently under review)
ASCIA Position Statement - Immunoglobulin Therapies for COVID-19 New April 2020
ASCIA Webinar - Part 1: HAE. Part 2: COVID-19 New April 2020
Guidelines – Standardised infusion rates for intravenous immunoglobulin (IVIg) replacement therapy
Primary immunodeficiencies (PID) Clinical Update
Primary immunodeficiencies (PID) e-training
Hereditary Angioedema (HAE) Position Paper and Management Plan
ASCIA Primary Immunodeficiency Strategy Under development
Content updated September 2020
